C Stone Pharmaceuticals
Pharmaceuticals, 1000 Zhangheng Rd, Shanghai, Maryland, 21502, United States, 201-500 Employees
Phone Number: 86**********
Who is CSTONE PHARMACEUTICALS
CStone (HKEX: 2616) is a biopharmaceutical company focused on researching, developing, and commercializing innovative immuno-oncology and precision medicines to address the unmet medical ...
Read More
-
Headquarters: 1000 Zhangheng Rd, Shanghai, Maryland, 21502, United States
-
Date Founded: 2016
-
Employees: 201-500
-
Revenue: $25 Million to $50 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from CSTONE PHARMACEUTICALS
CStone Pharmaceuticals Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding CStone Pharmaceuticals
Answer: CStone Pharmaceuticals's headquarters are located at 1000 Zhangheng Rd, Shanghai, Maryland, 21502, United States
Answer: CStone Pharmaceuticals's phone number is 86**********
Answer: CStone Pharmaceuticals's official website is https://cstonepharma.com
Answer: CStone Pharmaceuticals's revenue is $25 Million to $50 Million
Answer: CStone Pharmaceuticals's SIC: 2834
Answer: CStone Pharmaceuticals's NAICS: 325412
Answer: CStone Pharmaceuticals has 201-500 employees
Answer: CStone Pharmaceuticals is in Pharmaceuticals
Answer: CStone Pharmaceuticals contact info: Phone number: 86********** Website: https://cstonepharma.com
Answer: CStone (HKEX: 2616) is a biopharmaceutical company focused on researching, developing, and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and worldwide. Established in 2015, CStone has assembled a world-class management team with extensive experience in innovative drug development, clinical research, and commercialization. The company has built an oncology-focused pipeline of 15 drug candidates with a strategic emphasis on immuno-oncology combination therapies. Currently, CStone has received ten NDA approvals for four drugs. Multiple late-stage drug candidates are now under pivotal clinical trials or registration. CStone's vision is to become globally recognized as a world-renowned biopharmaceutical company by bringing innovative oncology therapies to cancer patients worldwide.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month